Amgen Inc.
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
Last updated:
Abstract:
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Status:
Application
Type:
Utility
Filling date:
18 Nov 2019
Issue date:
28 May 2020